RATIONALEPROF. S. DURAN GARCIA SPAIN

Gestational Diabetes Mellitus (GDM) was defined as a biochemical disturbance of glucose tolerance first diagnosed during pregnancy. With the clasic diagnostic criteria (NDDG, Carpenter and Coustam) 7% of pregnancies developped GDM in USA and in WEST EUROPEAN countries.

DURING THE MGSD MEETING HELD IN MARRAKECH WE REVIEWED THE CONSEQUENCES OF APPLYING THE DIAGNOSTIC CRITERIA OF CARPENTER AND COUSTAN PUBLISHED IN 1998, COMPARED TO THE CLASSICAL NDDG CRITERIA, IN THE SPANISH POPULATION OF PATIENTS WITH GESTATIONAL DIABETES. (GESTATIONAL DIABETES: CONSEQUENCES OF THE APPLICATION OF THE 1998 CRITERIA. MGSD CONGRESS. MARRAKECH, 2000).

FIRST STEP : “DIABETES AND THE MEDITERRANEAN DIET” WORKSHOP THAT WAS HELD IN PARIS ON 2 MARCH 2007.

SECOND : THE EFFECT OF THE MEDITERRANEAN DIET ON THE DEVELOPEMENT OF GESTATIONAL DIABETES. BOARD OF MGSD, PARIS, 2008.

AFTER THE PUBLICATION OF THE HAPO STUDY, A RE-EVALUATION OF THE PREVIOUS RESULTS ON THE PREVALENCE OF GESTATIONAL DIABETES IS NECESSARY. BOARD MGSD, MALTA, 2009.

HENCE THE IMPORTANCE OF THE STUDY SPONSORED BY THE MGSD THAT INTENDS TO UPDATE THE PREVALENCE OF GESTATIONAL DIABETES IN MEDITERRANEAN COUNTRIES. IT WILL NOT ONLY PROVIDE BETTER KNOWLEDGE OF THE REAL MAGNITUDE OF THIS CLINICAL PROBLEM, BUT WILL ALSO ATTEMPT TO EVALUATE THE RELATION TO PERINATAL COMPLICATIONS AND TO THE DEVELOPMENT OF GLUCOSE INTOLERANCE POST-PARTUM. THE IMPORTANCE OF THE EATING HABITS OF THE POPULATION UNDER STUDY AND THEIR POSSIBLE RELATION TO THE APPEARANCE OF GESTATIONAL DIABETES IS A MAIN ASPECT THAT IS BEING CONSIDERED IN THE MGSD STUDY.

“THE IMPACT OF RISK FACTORS AND MORE STRINGENT DIAGNOSTIC CRITERIA OF GESTATIONAL DIABETES ON OUTCOMES IN CENTRAL EUROPEAN WOMEN”

THE AUSTRIAN GESTATIONAL DIABETES STUDY GROUP

J CLIN ENDOCRINOL METAB 93, 1689-1695, 2008

THE 6th INTERNATIONAL SYMPOSIUM ON DIABETES & PREGNANCY

SALZBURG, AUSTRIA. MARCH 23-26, 2011

“IADPSG PROCESS FOR DEVELOPING RECOMMENDATIONS ON THE DIAGNOSIS AND CLASSIFICATION OF HYPERGLYCEMIA IN PREGNANCY AND GUIDLINESS FOR THEIR APPLICATION” B.E. METZGER

“HAPO RESULTS THAT SUPPORT THE IADPSG RECOMMENDATIONS” Donald COUSTAN

F. Dunne et al. IRELAND Y.B. Kotov et al. RUSSIA (MOSCOW

REGION) G. Tamas et al. HUNGARY K. Birkeland et al. OSLO. NORWAY I. Yasuhi et al. JAPAN J. Brazert et al. POLAND

COMPARISON OFWHO, IADPSG AND HAPO CRITERIA

IADPSG vs WHO 12% and 9.5% in Ireland ---- 4.0% in Moscow Region 20 % and 9.0 % in Hungary 24-41 % and 10.9-17.0 % in Oslo (Norway) 7.0 % and 3.5 % in Japan

IADPSG and HAPO criteria were related to increased prevalence of maternal metabolic syndrome and neonatal macrosomia